SurePath with STD Panel 1 by NAAT (Pap) : 1004483

Test Code
SUREPSTDP12P or 1004483

Alias/See Also
Sure Path

CPT Codes
88142, 87491, 87591, 87661

Includes
Panel includes SurePath Pap smear with Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis.

Instructions
Materials needed:
SurePath Preservative fluid collection vial (Client Supply # P490527), Broom device OR Combination Plastic Spatula/Brush.

Collection:

Broom--Insert the central bristles into the endocervical canal until the shorter side bristles contact the ectocervical face. Rotate the broom in a clockwise direction only, one complete turn. Detach the broom portion of the collection device into the preservative collection vial.

OR

Plastic Spatula/Brush--Insert the contoured end of the plastic spatula into the cervical os and rotate one complete turn sampling the ectocervix. Detach the end of the spatula and place in the preservative collection vial. Next place the tip of the brush device into the endocervical canal and rotate one half turn in one direction. Detach the end of the brush device and place in the preservative collection vial with the spatula device.

Transport Container
After collection of the sample, secure the lid to the vial. Label the vial with the patient's name, date of birth and specimen source. Place in a plastic specimen bag along with a completed requisition for transport to the laboratory.

Transport Temperature
Ambient.

Specimen Stability
Ambient: 1 month; Refrigerated: Unacceptable; Frozen: Unacceptable

Methodology
SurePath and Nucleic acid amplification testing (NAAT)

Setup Schedule
Monday - Friday

Report Available
Pap:
Negative: 1-2 days
Abnormal: 3-5 days

NAAT: 1-4 days

Reference Range
Pap: An interpretive report will be provided.

NAAT: Target Not Detected (TND)

Clinical Significance
Bacterial, yeast, viral and parasitic infections in women typically cause vaginitis, urethritis, and cervicitis. Common symptoms include vaginal discharge, vulvovaginal irritation, and/or dysuria. However, recurrent and/or untreated sexually transmitted infections (STIs) can result in ectopic pregnancy, infertility, and the possible risk of physical and developmental disabilities in fetus, including fetal death in few cases. Healthcare providers must assess the risk of STIs and provide counseling for prevention and treatment for all women of childbearing age. Nucleic acid amplification testing (NAAT) is analytically more sensitive than culture and antigen detection methods and is recommended for targeted STI screening and prevention.

The customized STD Panel 1 by NAAT, with PAP offers a combined menu to screen for cervical cancer using the Liquid Based Pap and testing for multiple STD infections using molecular techniques. This helps physicians to get multiple actionable results in a timely manner using clinically-proven technologies. The panel detects Neisseria gonorrhea, Chlamydia trachomatis and Trichomonas vaginalis in addition to the Liquid Based Pap.

Performing Laboratory
PBM and med fusion



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.